Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium,Catheterization & Cardiovascular Interventions

当前位置： X-MOL 学术 › Catheter. Cardiovasc. Interv. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium
Catheterization & Cardiovascular Interventions ( IF 2.3 ) Pub Date : 2021-08-31 , DOI: 10.1002/ccd.29932
Jens Wiebe ₁ , Felix J Hofmann ₂ , Nick West ₃ , Andreas Baumbach ₄ , Didier Carrie ₅ , Eduardo Pinar Bermudez ₆ , Guillaume Cayla ₇ , Felipe Hernandez Hernandez ₈ , Jose M de la Torre Hernandez ₉ , René Koning ₁₀ , Bruno Loi ₁₁ , Elisabetta Moscarella ₁₂ , Giuseppe Tarantini ₁₃ , Azfar Zaman ₁₄ , Christiane Lober ₁₅ , Thomas Riemer ₁₅ , Stephan Achenbach ₁₆ , Christian W Hamm _{2,

17} , Holger M Nef ₂ ,

Affiliation

Department of Cardiology, Deutsches Herzzentrum Muenchen, Munich, Germany.
Medizinische Klinik I, University of Giessen, Giessen, Germany.
Department of Cardiology, Royal Papworth Hospital, Cambridge, UK.
Barts Heart Centre, Queen Mary University of London, London, UK.
Sevice de cardiologie, CHU Toulouse, Université Paul Sabatier, Toulouse, France.
Department of Interventional Cardiology, Hospital Virgen de la Arrixaca, Murcia, Spain.
Service de cardiologie, CHU Nîmes, Université de Montpellier, Montpellier, France.
Department of Cardiology and Cardiac Surgery, Clinica Universidad de Navarra, Madrid, Spain.
Department of Interventional Cardiology, Hospital Marques de Valdecilla, Santander, Spain.
Département de Cardiologie, Clinique Saint-Hilaire, Rouen, France.
Interventional Cardiology, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Department of Translational Medical Sciences, University of Campania, Naples, Italy.
Interventional Cardiology, University of Padua, Padua, Italy.
Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
IHF GmbH Institut für Herzinfarktforschung, Ludwigshafen, Germany.
Department of Cardiology, Friedrich-Alexander-University of Erlangen, Erlangen, Germany.
Kerckhoff Heart and Thorax Center, Department of Cardiology, Bad Nauheim, Germany.

To asses mid-term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the treatment of coronary artery disease in a large-scale all-comers population.

中文翻译：